BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22982886)

  • 1. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
    Panarelli NC; Sela R; Schreiner AM; Crapanzano JP; Klimstra DS; Schnoll-Sussman F; Pochapin MB; Yantiss RK
    Am J Surg Pathol; 2012 Oct; 36(10):1434-43. PubMed ID: 22982886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
    Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
    Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts.
    Al-Haddad M; DeWitt J; Sherman S; Schmidt CM; LeBlanc JK; McHenry L; Coté G; El Chafic AH; Luz L; Stuart JS; Johnson CS; Klochan C; Imperiale TF
    Gastrointest Endosc; 2014 Jan; 79(1):79-87. PubMed ID: 23845445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cystic lesions without overt cytologic atypia: proposed diagnostic categories for endoscopic ultrasound-guided fine-needle aspiration cytology with utilization of fluid carcinoembryonic antigen level.
    Madan R; Khan E; Cuka N; Olyaee M; Tawfik O; Fan F
    Acta Cytol; 2012; 56(1):34-40. PubMed ID: 22236743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent Accuracy of Glucose Level in Cystic Fluid for Diagnosis of Pancreatic Mucinous Cysts.
    Faias S; Pereira L; Roque R; Chaves P; Torres J; Cravo M; Pereira AD
    Dig Dis Sci; 2020 Jul; 65(7):2071-2078. PubMed ID: 31705344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in diffusion-weighted magnetic resonance imaging as a tool in differentiation of serous cystadenoma and mucinous cystic tumor: a prospective study.
    Schraibman V; Goldman SM; Ardengh JC; Goldenberg A; Lobo E; Linhares MM; Gonzales AM; Abdala N; Abud TG; Ajzen SA; Jackowsky A; Szejnfeld J
    Pancreatology; 2011; 11(1):43-51. PubMed ID: 21412024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts.
    Basar O; Yuksel O; Yang DJ; Samarasena J; Forcione D; DiMaio CJ; Wagh MS; Chang K; Casey B; Fernandez-Del Castillo C; Pitman MB; Brugge WR
    Gastrointest Endosc; 2018 Jul; 88(1):79-86. PubMed ID: 29510146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
    Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD
    Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudocyst of the pancreas: the role of cytology and special stains for mucin.
    Gonzalez Obeso E; Murphy E; Brugge W; Deshpande V
    Cancer; 2009 Apr; 117(2):101-7. PubMed ID: 19365837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
    Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
    Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
    Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.